KIAA0513 and pachyonychia congenita: CaPSCs isolated from PC patients and PSCs isolated from benign patients and fostered with the cancer cell line PANC-1 revealed that Chr7:154954255-154998784+ might boost the development of PC by means of the miR-4459/KIAA0513 axis within CaPSCs and become a pivotal target for the treatment of PC patients in the future (44).